Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease

被引：4
|
作者：
Sugai, Fuminobu [1 ]
Kokunai, Yosuke [1 ]
Yamamoto, Yoichi [1 ]
Hashida, Goichi [2 ]
Shimazu, Kengo [2 ]
Mihara, Masahito [1 ]
Inoue, Satoru [2 ]
Sakoda, Saburo [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Neurol D4, Suita, Osaka 5650871, Japan
[2] Osaka Univ Hosp, Rehabil Unit, Osaka 553, Japan
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷 / 03期
关键词：
Pompe disease; Late onset; Muscle volume analyzer; Bioelectric impedance; Handheld dynamometer;
D O I：
10.1007/s00415-009-5367-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The muscle volume analyzer (MVA) can predict limb muscle weight based on bioelectric impedance analysis, whereas the conventional handheld dynamometer (HHD) measures muscle strength. In this study, a 26-year-old female on invasive ventilation due to late-onset Pompe disease was treated with enzyme replacement therapy (ERT) for 12 months. MVA measurements demonstrated time-dependent improvement from the baseline compared to HHD measurements, showing remarkably fluctuating muscle strength. Thus, the MVA can be used as an alternative, particularly for patients suffering from severe limb muscle weakness.
引用
收藏
页码：461 / 463
页数：3
相关论文
共 50 条
  • [41] Respiratory muscle training in late-onset Pompe disease
    Jones, Harrison N.
    Nicholson, Kaylea
    Crisp, Kelly D.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S72 - S72
  • [42] Magnetic Resonance Imaging (MRI) to evaluate the effect of enzyme replacement therapy in Late Onset Pompe Disease (LOPD)
    Corti, M.
    Baligand, C.
    Falk, L.
    Walter, G. A.
    Byrne, B. J.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 827 - 827
  • [43] Enzyme replacement therapy in late-onset Pompe's disease: A three-year follow-up
    Winkel, LPF
    Van den Hout, JMP
    Kamphoven, JHJ
    Disseldorp, JAM
    Remmerswaal, M
    Arts, WFM
    Loonen, MCB
    Vulto, AG
    Van Doorn, PA
    De Jong, G
    Hop, W
    Smit, GPA
    Shapira, SK
    Boer, MA
    van Diggelen, OP
    Reuser, AJJ
    Van der Ploeg, AT
    ANNALS OF NEUROLOGY, 2004, 55 (04) : 495 - 502
  • [44] Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy
    Terzis, Gerasimos
    Dimopoulos, Filippos
    Papadimas, George K.
    Papadopoulos, Constantinos
    Spengos, Konstantinos
    Fatouros, Ioannis
    Kavouras, Stavros A.
    Manta, Panagiota
    MOLECULAR GENETICS AND METABOLISM, 2011, 104 (03) : 279 - 283
  • [45] Effect of Aerobic and Resistance Exercise Training on Late-Onset Pompe Disease Patients Receiving Enzyme Replacement Therapy
    Terzis, Gerasimos
    Papadimas, Georgios K.
    Dimopoulos, Filippos
    Papadopoulos, Costas
    Spengos, Konstantinos
    Fatouros, Ioannis
    Kavouras, Stavros
    Manta, Panagiota
    CLINICAL THERAPEUTICS, 2011, 33 : S40 - S40
  • [46] Long-term enzyme replacement therapy with alglucosidase alfa in children and adults with late-onset Pompe disease
    Theunissen, M.
    van Kooten, H.
    Harlaar, L.
    Ismailova, G.
    van den Hout, J.
    Rizopoulos, D.
    Boon, M.
    Brusse, E.
    van Doorn, P.
    van der Ploeg, A.
    van der Beek, N.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S150 - S150
  • [47] Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy
    Terzis, Gerasimos
    Krase, Argyro
    Papadimas, Giorgos
    Papadopoulos, Constantinos
    Kavouras, Stavros A.
    Manta, Panagiota
    MOLECULAR GENETICS AND METABOLISM, 2012, 107 (04) : 669 - 673
  • [48] Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients
    Sheng B.
    Chu Y.P.
    Wong W.T.
    Yau E.K.C.
    Chen S.P.L.
    Luk W.H.
    BMC Research Notes, 10 (1)
  • [49] Long-term effects of enzyme replacement therapy in an elderly cohort of late-onset Pompe disease patients
    Winkler, M.
    von Landenberg, C.
    Kuchenbecker, K.
    Reimann, J.
    Kornblum, C.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S50 - S50
  • [50] Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease
    Papadopoulos, Constantinos
    Orlikowsld, David
    Prigent, Helene
    Lacour, Arnaud
    Tard, Celine
    Furby, Alain
    Praline, Julien
    Sole, Guilhem
    Hogrel, Jean-Yves
    De Antonio, Marie
    Semplicini, Claudio
    Deibener-Kaminsky, Joelle
    Kaminsky, Pierre
    Eymard, Bruno
    Taouagh, Nadjib
    Perniconi, Barbara
    Hamroun, Dalil
    Laforet, Pascal
    Bassez, G.
    Bedat-Millet, A. -L.
    Behin, A.
    Eymard, B.
    Leonard -Louis, S.
    Stojkovic, T.
    Canal, A.
    Decostre, V.
    Bouhour, F.
    Boyer, F.
    Caillaud, C.
    Castaing, Y.
    Chapon, F.
    Cintas, P.
    Durieu, I.
    Echaniz-Laguna, A.
    Feasson, L.
    Ferrer, X.
    Froissart, R.
    Piraud, M.
    Germain, D.
    Benistan, K.
    Guffon-Fouilhoux, N.
    Journel, H.
    Labauge, P.
    Levy, A.
    Magot, A.
    Pereon, Y.
    Minot-Myhie, M-C
    Nadaj-Pakleza, A.
    Nathier, C.
    Pellegrini, N.
    MOLECULAR GENETICS AND METABOLISM, 2017, 122 (1-2) : 80 - 85
12345